> California Attorney General Bill Lockyer has added 37 pharmaceutical companies to a lawsuit claiming they gouged the state's Medi-Cal program for the poor by charging prices that sometimes reached 10 times what many pharmacies and others were charged. Amgen, Bristol-Myers, GlaxoSmithKline, Novartis and dozens of other major drug companies have been added to the case, which echoes charges in more than a dozen states that the drug companies gamed the state health agencies' pricing system by artificially inflating average wholesale prices. Story
> The American Diabetes Foundation says that diagnosing patients with metabolic syndrome is poorly defined, based on incomplete information and may distract physicians from properly treating patients. Report
And Finally... A new survey from the Kaiser Family Foundation found that a growing number of seniors are warming to the new Medicare drug subsidy, but more say they will not sign up for it than those who say they will. Article